NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
7.97
+0.41 (5.42%)
At close: Nov 16, 2026, 4:00 PM EST
7.82
-0.15 (-1.88%)
After-hours: Nov 16, 2026, 7:39 PM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $274.58 million as of November 16, 2026. It is the 18,403rd most valuable company in the world and the 3,236th biggest in the United States. Its market cap has decreased by 36.29% in one year.
Market Cap
274.58M
Enterprise Value
294.89M
1-Year Change
-36.29%
Global Rank
Country Rank
#3,236 United States
Category
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $274.58M, a decrease of -30.18%. That is a compound annual growth rate of -6.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 274.58M | -46.61% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 345.50M |
| SS Innovations International | 332.64M |
| CapsoVision | 323.27M |
| InfuSystem Holdings | 294.89M |
| Orthofix Medical | 292.25M |
| Standard BioTools | 279.27M |
| Profound Medical | 272.42M |
| ClearPoint Neuro | 271.82M |